T-Cell Modulation for the Treatment of Chronic Plaque Psoriasis with Efalizumab (Raptiva™): Mechanisms of Action von Jullien, D., Prinz, J.C., Langley, R.G.B., Caro, I., Dummer, W., Joshi, A., Dedrick, R., Natta, P.

Volltext

No elevated risk for depression, anxiety or suicidality with secukinumab in a pooled analysis of data from 10 clinical studies in moderate‐to‐severe plaque psoriasis von Strober, B.E., Langley, R.G.B., Menter, A., Magid, M., Porter, B., Fox, T., Safi, J., Papavassilis, C.

Volltext

Secukinumab re‐initiation achieves regain of high response levels in patients who interrupt treatment for moderate to severe plaque psoriasis von Blauvelt, A., Reich, K., Warren, R.B., Szepietowski, J.C., Sigurgeirsson, B., Tyring, S. K., Messina, I., Bhosekar, V., Oliver, J., Papavassilis, C., Frueh, J., Langley, R.G.B.

Volltext

THU0187 Safety of Tofacitinib, An Oral Janus Kinase Inhibitor: Integrated Data Analysis from The Global Chronic Plaque Psoriasis Clinical Trials von Langley, R.G.B., Cohen, A.D., Foley, P., Griffiths, C.E.M., Lebwohl, M., Leonardi, C., Winthrop, K., Proulx, J., Rottinghaus, S.T., Wolk, R., Thompson, J.R., Tatulych, S., Mallbris, L., Swanson, R.

Volltext

Acute cholecystitis from metastatic melanoma to the gall–bladder in a patient with a low–risk melanoma von LANGLEY, R.G.B., BAILEY, E.M., SOBER, A.J.

Volltext

Acute cholecystitis from metastatic melanoma to the gall–bladder in a patient with a low–risk melanoma von LANGLEY, R.G.B., BAILEY, E.M., SOBER, A.J.

Volltext

Acute cholecystitis from metastatic melanoma to the gall-bladder in a patient with a low-risk melanoma von LANGLEY, R.G.B., BAILEY, E.M., SOBER, A.J.

Volltext

Clinical real-time confocal imaging of human skin and oral tissues in vivo von Rajadhyaksha, M., Langley, R.G.B., Gonzalez, S., White, M., Zavislan, J.M., Webb, R.H., Anderson, R.R.

Volltext